194 related articles for article (PubMed ID: 25733057)
1. Role of MicroRNAs in Prostate Cancer Pathogenesis.
Wang YL; Wu S; Jiang B; Yin FF; Zheng SS; Hou SC
Clin Genitourin Cancer; 2015 Aug; 13(4):261-270. PubMed ID: 25733057
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
4. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
6. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
8. Implications of microRNA dysregulation in the development of prostate cancer.
Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
[TBL] [Abstract][Full Text] [Related]
9. Roles of microRNAs during prostatic tumorigenesis and tumor progression.
Fang YX; Gao WQ
Oncogene; 2014 Jan; 33(2):135-47. PubMed ID: 23455326
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑512‑3p is upregulated, and promotes proliferation and cell cycle progression, in prostate cancer cells.
Rao Z; He Z; He Y; Guo Z; Kong D; Liu J
Mol Med Rep; 2018 Jan; 17(1):586-593. PubMed ID: 29115469
[TBL] [Abstract][Full Text] [Related]
11. Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.
Ceder Y
Adv Exp Med Biol; 2016; 886():155-170. PubMed ID: 26659491
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs targeting prostate cancer stem cells.
Fang YX; Chang YL; Gao WQ
Exp Biol Med (Maywood); 2015 Aug; 240(8):1071-8. PubMed ID: 25966983
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and drug resistance in prostate cancers.
Li F; Mahato RI
Mol Pharm; 2014 Aug; 11(8):2539-52. PubMed ID: 24742219
[TBL] [Abstract][Full Text] [Related]
15. Androgens and prostate cancer bone metastases: effects on both the seed and the soil.
Yang W; Levine AC
Endocrinol Metab Clin North Am; 2011 Sep; 40(3):643-53, x. PubMed ID: 21889726
[TBL] [Abstract][Full Text] [Related]
16. The role of microRNAs in prostate cancer migration, invasion, and metastasis.
Aghdam SG; Ebrazeh M; Hemmatzadeh M; Seyfizadeh N; Shabgah AG; Azizi G; Ebrahimi N; Babaie F; Mohammadi H
J Cell Physiol; 2019 Jul; 234(7):9927-9942. PubMed ID: 30536403
[TBL] [Abstract][Full Text] [Related]
17. Missing link between microRNA and prostate cancer.
Gill BS; Alex JM; Navgeet ; Kumar S
Tumour Biol; 2016 May; 37(5):5683-704. PubMed ID: 26822307
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
20. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
